Meet UF’s Nicholas Rudawski: YouTube Star in Electron Microscopy Education (UF HWCE)
Nicholas Rudawski, Ph.D., an electron microscopy expert at the University of Florida’s Nanoscale Research Facility (NRF), is helping students and researchers from around the world use electron microscopes and understand electron microscopy, one video at a time.
UF Health Cancer Institute Again Recognized as a State Cancer Center of Excellence (UF Health)
The University of Florida Health Cancer Institute has once again been recognized as a Cancer Center of Excellence by Gov. Ron DeSantis and the Florida Department of Health.
UF Astraeus Faculty Help Shape National Science Strategy for Human Exploration of Mars (UF News)
Two University of Florida researchers with the Astraeus Space Institute played key leadership roles in a major National Academies of Sciences, Engineering and Medicine report released in December that will help guide U.S. science priorities for future human missions to Mars.
Oragenics Partners With DUCK FLATS Pharma To Support FDA IND Readiness and Clinical Trial Design for Concussion Program (Globe Newswire)
UF Innovate | Accelerate graduate Oragenics announced it has engaged DUCK FLATS Pharma as its U.S. Investigational New Drug (IND) readiness and regulatory execution partner to support FDA-facing preparation and clinical trial design as the Company advances its novel intranasal concussion therapy toward U.S.-based development.
Tech Tuesday: University of Florida Lab Predicts Patient Cancer Treatment Outcomes Through Artificial Intelligence (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate spotlights AI-driven cancer research by UF professor Raquel Dias, who uses AI to predict patient treatment outcomes across the life sciences, agricultural sciences, and human health.
TuHURA Biosciences Received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB To Stage IV Cutaneous Melanoma (TuHURA Biosciences)
TuHURA Biosciences, formed by CohBar and Morphogenesis, a UF startup, announced that the U.S FDA has granted Orphan Drug Designation (ODD) to IFx-2.0 for the treatment of stage IIB to stage IV cutaneous melanoma.
Tech Tuesday: University of Florida Introduces a Concrete 3D Printer Capable of Building Structures (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate spotlights the COBOD Concrete 3D Printer right here in Gainesville.
Harnessing AI With Drone Imagery To Detect Costly Celery Disease Before Symptoms Surface (UF News)
UF researchers are launching a grant-funded project using AI with drone imagery to detect costly celery disease before symptoms appear, helping growers prevent major crop losses and reduce costs.
Myosin Therapeutics Invited To Present at Biocom California’s Global Partnering & Investor Conference (PR Newswire)
UF startup Myosin Therapeutics has been selected to present at Biocom California’s Global Partnering & Investor Conference. Company leadership will share progress and engage with investors and strategic partners, highlighting continued momentum in advancing its therapeutic pipeline.
UF Innovate Launches Spring 2026 NSF I-Corps Semiconductor Regional Course (UF FSI)
UF Innovate officially kicks off its Spring 2026 NSF I‑Corps Semiconductor Regional Course. This program brings together 47 participants across 15 teams from UF, USF, and UCF, supported by five seasoned industry and entrepreneurial mentors, to explore the commercial potential of semiconductor technologies.